During the past years, increasing evidence supports the contribution of TCF19 to tumor progression by controlling cellular proliferation in several cancer types [13, 14, 15, 16, 17, 18, 19, 20] through a mechanism that is mediated, at least in part, by targeting the FOXO1 pathway [19, 20]. The gene discussed is TCF19; the disease is neoplasm.